In patients with PSA of “grey zone” (4.0-10.0 ng/ml, n=339), IPP was indicated to be associated with positive rate of prostate cancer and integrating it with tPSA could significantly increase the predictive accuracy7. Here, KLK3 is linked to prostate cancer.